Does AMISULPRIDE Cause Obesity? 105 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Obesity have been filed in association with AMISULPRIDE (Barhemsys). This represents 3.3% of all adverse event reports for AMISULPRIDE.
105
Reports of Obesity with AMISULPRIDE
3.3%
of all AMISULPRIDE reports
1
Deaths
94
Hospitalizations
How Dangerous Is Obesity From AMISULPRIDE?
Of the 105 reports, 1 (1.0%) resulted in death, 94 (89.5%) required hospitalization, and 1 (1.0%) were considered life-threatening.
Is Obesity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMISULPRIDE. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does AMISULPRIDE Cause?
Drug ineffective (665)
Weight increased (346)
Toxicity to various agents (305)
Suicide attempt (261)
Akathisia (252)
Extrapyramidal disorder (226)
Drug abuse (219)
Leukopenia (218)
Therapeutic product effect incomplete (200)
Off label use (191)
What Other Drugs Cause Obesity?
RISPERIDONE (3,039)
PREDNISONE (1,880)
METHOTREXATE (1,876)
ADALIMUMAB (1,780)
TOCILIZUMAB (1,630)
ABATACEPT (1,605)
INFLIXIMAB (1,536)
HYDROXYCHLOROQUINE (1,532)
SULFASALAZINE (1,455)
ETANERCEPT (1,407)
Which AMISULPRIDE Alternatives Have Lower Obesity Risk?
AMISULPRIDE vs AMITRIPTYLINE
AMISULPRIDE vs AMITRIPTYLINE\PERPHENAZINE
AMISULPRIDE vs AMIVANTAMAB
AMISULPRIDE vs AMIVANTAMAB-VMJW
AMISULPRIDE vs AMLODIPINE